Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 876 - 900 of 13643 in total
Phleum pratense pollen allergenic extract is used in allergenic testing.
Approved
Investigational
Matched Description: … Phleum pratense pollen allergenic extract is used in allergenic testing. …
Matched Mixtures name: … SLITone ULTRA D. glomerata/ L. perenne/ P. pratense/ P. pratensis/ A. odoratum …
A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Approved
Matched Description: … A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity …
Matched Categories: … Antibacterials for Systemic Use ... Antiinfectives for Systemic Use …
Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria.
Approved
Matched Description: … Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria. …
Matched Mixtures name: … Altidec A ... Dimetapp Chewables for Kids …
Matched Categories: … Antihistamines for Systemic Use …
Bovine adenosine deaminase derived from bovine intestine that has been extensively pegylated for extended serum half life.
Approved
Matched Description: … Bovine adenosine deaminase derived from bovine intestine that has been extensively pegylated for extended …
Dolasetron is an antinauseant and antiemetic agent indicated for the prevention of nausea and vomiting associated with moderately-emetogenic cancer chemotherapy and for the prevention of postoperative nausea and vomiting. Dolasetron is a highly specific and selective serotonin 5-HT3 receptor antagonist. This drug is not shown to have activity at other...
Approved
Investigational
Matched Description: … Dolasetron is a highly specific and selective serotonin 5-HT3 receptor antagonist. ... Dolasetron is an antinauseant and antiemetic agent indicated for the prevention of nausea and vomiting ... associated with moderately-emetogenic cancer chemotherapy and for the prevention of postoperative nausea …
Ciclesonide is a glucocorticoid used to treat obstructive airway diseases. It is marketed under the brand name Alvesco.
Approved
Investigational
Matched Description: … Ciclesonide is a glucocorticoid used to treat obstructive airway diseases. …
Matched Categories: … Drugs for Obstructive Airway Diseases …
Febrile neutropenia (FN), defined as the co-occurrence of fever (temperature > 38 ◦C) and severe neutropenia (ANC < 500 cells/mm3), is a potential side effect of myelosuppressive chemotherapy in which the patient develops an infection during a period of significant neutropenia. It typically develops during the first cycle of chemotherapy...
Approved
Investigational
Matched Description: … [L43135] In September 2022, eflapegrastim was approved by the US FDA as a prophylactic against infection ... chemotherapy regimen being administered - regimens are classified as either high-, intermediate-, or low-risk for ... a period of significant neutropenia. …
Pipecuronium is a piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent.
Approved
Matched Iupac: … 1,7-bis(acetyloxy)-8-(4,4-dimethylpiperazin-4-ium-1-yl)-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a] …
Matched Description: … Pipecuronium is a piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking …
Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.
Approved
Matched Description: … Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) …
Matched Categories: … Antihypertensive Agents Indicated for Hypertension …
A benzodiazepine derivative used as an anticonvulsant and hypnotic.
Approved
Matched Description: … A benzodiazepine derivative used as an anticonvulsant and hypnotic. …
Aspergillus flavus is a fungus which can provoke allergic reactions. Aspergillus flavus extract is used in allergenic testing.
Approved
Matched Description: … Aspergillus flavus extract is used in allergenic testing. ... Aspergillus flavus is a fungus which can provoke allergic reactions. …
Matched Mixtures name: … A Mold Mixture ... A Mold Mixture ... A Mold Mixture …
Approved
Vet approved
Matched Iupac: … acetyl]-10-hydroxy-5,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a] …
Primidone is an anticonvulsant used to treat essential tremor as well as grand mal, psychomotor, and focal epileptic seizures. Primidone was developed by J Yule Bogue and H C Carrington in 1949. Primidone was granted FDA Approval on 8 March 1954.
Approved
Vet approved
Matched Description: … [L11112] Primidone was developed by J Yule Bogue and H C Carrington in 1949. …
Aspergillus repens is a fungus which can provoke allergic reactions. Aspergillus repens extract is used in allergenic testing.
Approved
Matched Description: … Aspergillus repens extract is used in allergenic testing. ... Aspergillus repens is a fungus which can provoke allergic reactions. …
Matched Mixtures name: … A Mold Mixture ... A Mold Mixture ... A Mold Mixture …
Isopropamide iodide is a long-acting quaternary anticholinergic drug. It is used in the treatment of peptic ulcer and other gastrointestinal disorders marked by hyperacidity and hypermotility.
Approved
Vet approved
Matched Description: … Isopropamide iodide is a long-acting quaternary anticholinergic drug. ... It is used in the treatment of peptic ulcer and other gastrointestinal disorders marked by hyperacidity …
Matched Categories: … Drugs for Functional Gastrointestinal Disorders …
A potent, long-acting irreversible cholinesterase inhibitor used as an ocular hypertensive in the treatment of glaucoma. Occasionally used for accomodative esotropia.
Approved
Matched Description: … A potent, long-acting irreversible cholinesterase inhibitor used as an ocular hypertensive in the treatment ... Occasionally used for accomodative esotropia. …
Approved
Nutraceutical
Matched Categories: … Compounds used in a research, industrial, or household setting …
Acetarsol, with the molecular formula N-acetyl-4-hydroxy-m-arsanilic acid, is a pentavalent arsenical compound with antiprotozoal and antihelmintic properties. It was first discovered in 1921 by Ernest Fourneau at the Pasteur Institute. It was developed by Neolab Inc, and approved by Health Canada as an antifungal on December 31, 1964. It has...
Approved
Withdrawn
Matched Description: … [L2622] It was first discovered in 1921 by Ernest Fourneau at the Pasteur Institute. ... Acetarsol, with the molecular formula N-acetyl-4-hydroxy-m-arsanilic acid, is a pentavalent arsenical …
Rebamipide has been investigated for the treatment of Stomach Ulcer, Keratoconjunctivitis Sicca, and Gastric Adenoma and Early Gastric Cancer.
Approved
Investigational
Matched Description: … Rebamipide has been investigated for the treatment of Stomach Ulcer, Keratoconjunctivitis Sicca, and …
Matched Categories: … Compounds used in a research, industrial, or household setting ... Drugs for Acid Related Disorders ... Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord) …
Lecanemab is a recombinant humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid beta (Aβ), which are implicated in the pathophysiology of Alzheimer’s disease. Lecanemab works to reduce Aβ plaques and prevent Aβ deposition in the brain [A253947,A253952] with high selectivity to Aβ...
Approved
Investigational
Matched Description: … Lecanemab is a recombinant humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against ... [A253962,L44547] On January 6, 2023, lecanemab was granted accelerated approval by the FDA for the ... [L44537] Lecanemab works to reduce Aβ plaques and prevent Aβ deposition in the brain [A253947,A253952 …
Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It has been classified differently according to its drug properties in which based on its chemical structure, gliclazide is considered a first-generation sulfonylurea due to the structural presence of a sulfonamide group able to release...
Approved
Matched Description: … Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes ... to decrease fasting plasma glucose, postprandial blood glucose and glycosolated hemoglobin (HbA1c) levels ... sulfonylurea which presents a higher potency and a shorter half-life. …
Matched Categories: … Drugs Used in Diabetes …
One of the cephalosporins that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms.
Approved
Investigational
Matched Description: … One of the cephalosporins that has a broad spectrum of activity against both gram-positive and gram-negative …
Matched Categories: … Antibacterials for Systemic Use ... Antiinfectives for Systemic Use …
Davesomeran is a mRNA vaccine used in conjunction with elasomeran as part of the Moderna Bivalent COVID-19 vaccine. Similar to the previous Moderna COVID-19 vaccine, Moderna Bivalent vaccine encodes the full-length pre-fusion stabilized spike (S) protein to elicit an immune response.[L43882,L28026] However, with the addition of davesomeran, Moderna Bivalent vaccine...
Approved
Investigational
Matched Description: … [L43882] In October 22nd 2022, the FDA approved the Moderna Bivalent Vaccine as a booster in patients ... Davesomeran is a mRNA vaccine used in conjunction with [elasomeran] as part of the Moderna Bivalent COVID ... [L43882] A phase 2 and 3 open-label study in participants 18 years or older who had previously received …
Equine Botulinum Neurotoxin B Immune FAB2 is composed of a mixture of immune globulin fragments purified from plasma of horses that were previously immunized with botulinum toxin serotype B. It is intravenously administered for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes B in...
Approved
Experimental
Investigational
Matched Description: … exposure to botulinum neurotoxin serotypes B in adults and pediatric patients. ... Equine Botulinum Neurotoxin B Immune FAB2 is composed of a mixture of immune globulin fragments purified ... It is intravenously administered for the treatment of symptomatic botulism following documented or suspected …
A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.
Approved
Investigational
Matched Description: … A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary …
Displaying drugs 876 - 900 of 13643 in total